|

CBCT Guided Markerless SBRT for Renal Cell Cancer

RECRUITINGN/ASponsored by Erasmus Medical Center
Actively Recruiting
PhaseN/A
SponsorErasmus Medical Center
Started2026-04-01
Est. completion2030-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07402109

Summary

This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with histologically proven non-metastastic RCC or high suspicion of RCC based on imaging without histological evidence
* No metastatic lesions
* Patients must be 18 years or older
* Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician.

Written informed consent

Exclusion Criteria:

* Previous high-dose radiotherapy in the region of the kidney

Conditions2

CancerRenal Cell Carcinoma (RCC)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.